PDGFRB and neoplasm: Late-stage CAFs showed enrichment for Rgs5, Nfkb pathway, Serpins (a1d,a3f, e2, and i1), Timp1, Acta2 expression, and vCAF signatures, while Pdgfrb decreased with tumor progression (Elwakeel et al., 2019).